78 related articles for article (PubMed ID: 2395218)
21. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
[TBL] [Abstract][Full Text] [Related]
22. [Immunopathological study of proliferation-associated antigens in proliferative skin diseases].
Baba N
Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):147-52. PubMed ID: 2197470
[TBL] [Abstract][Full Text] [Related]
23. Benign and malignant lymphocytic skin infiltrates: immunological patterns recognized by immunohistochemical staining with monoclonal antibodies.
Ralfkiaer E; Hou-Jensen K; Mason DY; Stein H; Wantzin GL; Thomsen K
Adv Exp Med Biol; 1985; 186():1033-41. PubMed ID: 3876696
[TBL] [Abstract][Full Text] [Related]
24. A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma.
Dummer R; Potoczna N; Häffner AC; Zimmermann DR; Gilardi S; Burg G
Arch Dermatol; 1996 May; 132(5):550-3. PubMed ID: 8624152
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
26. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
Boldt DH; Phillips JL; Alcantara O
J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
Beljaards RC; Meijer CJ; Scheffer E; Toonstra J; van Vloten WA; van der Putte SC; Geerts ML; Willemze R
Am J Pathol; 1989 Dec; 135(6):1169-78. PubMed ID: 2556926
[TBL] [Abstract][Full Text] [Related]
29. Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin.
Burg G; Braun-Falco O; Hoffmann-Fezer G; Rodt H; Schmoeckel C
Dermatologica; 1978; 157(5):282-91. PubMed ID: 150349
[TBL] [Abstract][Full Text] [Related]
30. An ultrastructural morphometric and immunohistochemical analysis of cutaneous lymphomas and benign lymphocytic infiltrates of skin. Useful criteria for diagnosis.
Payne CM; Grogan TM; Lynch PJ
Arch Dermatol; 1986 Oct; 122(10):1139-54. PubMed ID: 3490225
[TBL] [Abstract][Full Text] [Related]
31. [Immunologic phenotyping of cutaneous lymphomas].
Kaudewitz P; Burg G; Smolle J; Braun-Falco O
Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
[TBL] [Abstract][Full Text] [Related]
32. [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas].
Smolle J; Kaudewitz P; Aberer E; Torne R; Burg G; Kerl H
Hautarzt; 1987 Aug; 38(8):461-6. PubMed ID: 3308776
[TBL] [Abstract][Full Text] [Related]
33. An epitope on the transferrin receptor preferentially exposed during tumor progression in human lymphoma is close to the ligand binding site.
Takahashi S; Esserman L; Levy R
Blood; 1991 Feb; 77(4):826-32. PubMed ID: 1704266
[TBL] [Abstract][Full Text] [Related]
34. Use of monoclonal antibodies (UCHL1, Ki-B3) against T and B cell antigens in routine paraffin-embedded skin biopsy specimens.
Sterry W; Hauschild A
J Am Acad Dermatol; 1989 Jul; 21(1):98-107. PubMed ID: 2473100
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous pheomorphic T cell lymphoma. Immunologic, virologic, and T-cell receptor gene rearrangement studies in one European case with initial pseudolymphoma presentation.
Bendelac A; Lesavre P; Boitard C; O'Connor NT; Laure F; Laroche L; Teillac D; de Prost Y; Bach JF
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):657-64. PubMed ID: 3534011
[TBL] [Abstract][Full Text] [Related]
36. Cell lineage analysis in cutaneous lymphoid infiltrates using a panel of monoclonal antibodies reactive in wax-embedded tissue.
van der Putte SC; Toonstra J; van Wichen DF; van Unnik JA; van Vloten WA
Curr Probl Dermatol; 1990; 19():124-31. PubMed ID: 2404673
[No Abstract] [Full Text] [Related]
37. Ki-1+ cutaneous lymphoma. Gene rearrangement analysis of tumor cells in tissue and short-term culture of a patient.
Sugimoto H; Nakayama F; Yamauchi T; Tokura Y; Iwatsuki K; Takigawa M; Yamada M; Maeda M
Arch Dermatol; 1988 Mar; 124(3):405-8. PubMed ID: 2830849
[TBL] [Abstract][Full Text] [Related]
38. Transferrin receptor expression in normal skin and in various cutaneous tumors.
Soyer HP; Smolle J; Torne R; Kerl H
J Cutan Pathol; 1987 Feb; 14(1):1-5. PubMed ID: 3549812
[TBL] [Abstract][Full Text] [Related]
39. An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas.
Esserman L; Takahashi S; Rojas V; Warnke R; Levy R
Blood; 1989 Dec; 74(8):2718-29. PubMed ID: 2479430
[TBL] [Abstract][Full Text] [Related]
40. Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma.
Holte H; de Lange Davies C; Beiske K; Stokke T; Marton PF; Smeland EB; Høie J; Kvaløy S
Int J Cancer; 1989 Dec; 44(6):975-80. PubMed ID: 2606582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
